Research Article
Oral Domiciliary Therapy of Multiple Myeloma with Cyclophosphamide, Pomalidomide and Dexamethasone Regimen in the Covid Era - A Pilot Study
Outcomes of Brentuximab Vedotin with or without Bendamustine and Nivolumab in Relapsed or Refractory Hodgkin’s Lymphoma: An Early Experience from Patient Access Programme in India
Case Report
Refractory Myeloma Developed with Multiple Extramedullary Tumors and Myelofibrosis
10.33140/AHOR.07.01.03